Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Noxopharm Ltd V.NOX


Primary Symbol: NOXOF

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.


OTCPK:NOXOF - Post by User

Bullboard Posts
Post by paperboy222on Nov 30, 2009 9:35pm
411 Views
Post# 16538381

4 Ferderber claims

4 Ferderber claims

This one might interest some of you.. I posted it over on AZX

Seems some drilling will be happening ? And could be interesting .

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 18, 2009) - TSX Venture Exchange daily Bullentins


ALEXANDRIA MINERALS CORPORATION ("AZX")
BULLETIN TYPE: Property-Asset or Share Purchase Agreement
BULLETIN DATE: November 18, 2009
TSX Venture Tier 2 Company


TSX Venture Exchange has accepted for filing documentation in connection
with a Letter Agreement dated October 5, 2009 between the Company and
Niogold Mining Corporation whereby the Company will participate in the
acquisition cost of 4 Ferderber claims located in Val d'Or, Quebec that
was accepted for filing under Niogold's bulletin dated August 28, 2009.
These properties will form part of the Siscoe East Property and will be
subject to the terms of the Option and Joint Venture Agreement dated June
25, 2008 between the Company and Niogold that was accepted for filing
effective July 8, 2008. Consideration payable by the Company will be
$15,000.00 and the issuance of 120,000 common shares.

Cheers

https://www.marketwire.com/press-release/Tsx-Venture-Exchange-Daily-Bulletins-1079042.html

Bullboard Posts